Phase I clinical trial of locoregional administration of the oncolytic adenovirus ONYX-015 in combination with mitomycin-C, doxorubicin, and cisplatin chemotherapy in patients with advanced sarcomas.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples